Glucose Lowering Agents/
                                        OD	Once a day			/
BiguanidesBD	                        BD Twice a day			/
1.	Metformin :                         OM	Once every morning	/
-	Formulation: 500/1000 mg /
    o	Minimum dose/
    Initial dose: 500 mg OD /
    o	Maximum dose/
    Usual dose: 1000 mg BD *Exception: 1000 mg TDS (follow doctor prescription)/
/
2.	Metformin Sustained Release : (takes longer time to dissolve)/
-	Formulation: 850 mg/
    o	Minimum dose/
    Usual dose: 850 mg BD /
    o	Maximum dose/
    850 mg TDS/
/
3.	Metformin Extended Release : (take much longer time to dissolve)/
-	Formulation: 500/750/1000 mg/
    o	Minimum dose/
    Initial dose: 500 mg OD/
    Usual dose: 2000 mg OD/
    o	Maximum dose/
    2000 mg OD/
/
Sulphonylureas/
1.	Glibenclamide :/
-	Formulation: 5 mg /
    o	Minimum dose/
    2.5	mg OD /
    o	Maximum dose/
    10 mg BD/
/
2.	Gliclazide :/
-	Formulation: 80 mg /
    o	Minimum dose/
    40 mg OM /
    o	Maximum dose/
    160 mg BD/
/
3.	Gliclazide Modified Release :/
-	Formulation: 60/30 mg /
    o	Minimum dose/
    30 mg OM /
    o	Maximum dose/
    120 mg OM/
/
4.	Glipizide :/
-	Formulation: 5 mg /
    o	Minimum dose/
    2.5 mg OM/
    o	Maximum dose /
    10 mg BD/
/
5.	Glimepiride :/
-	Formulation: 2/3 mg /
    o	Minimum dose/
    1 mg OM/
    o	Maximum dose/
    6 mg OM/
/
Meglitinides/
1.	Repaglinide :/
-	Formulation: 0.5/1/2 mg /
    o	Minimum dose/
    0.5 mg with main meal/
    o	Maximum dose/
    4 mg with main meals (not exceeding 16 mg daily)/
/
alpha-glucosidase inhibitor/
1.	Acarbose :/
-	Formulation: 50/100 mg /
    o	Minimum dose/
    Initial dose: 50 mg OD /
    Usual dose: 50-100 mg (take at 1st bite of main meals)/
    o	Maximum dose/
    100 mg TDS/
/
Thiazolidinedione/
1.	Rosiglitazone :/
-	Formulation: 4/8 mg /
    o	Minimum dose/
    4 mg OD /
    o	Maximum dose/
    8 mg OD/
/
2.	Pioglitazone :/
-	Formulation: 15/30 mg /
    o	Minimum dose/
    15 mg OD /
    o	Maximum dose/
    45 mg OD/
/
DPP4-inhibitors/
1.	Sitagliptin :/
-	Formulation: 25/50/100 mg /
    o	Minimum dose/
    25 mg OD /
    o	Maximum dose/
    100 mg OD/
/
2.	Vildagliptin :/
-	Formulation: 50 mg /
    o	Minimum dose/
    50 mg OD /
    o	Maximum dose/
    50 mg BD/
/
3.	Saxagliptin :/
-	Formulation: 2.5/5 mg /
    o	Minimum dose/
    2.5 mg OD /
    o	Maximum dose/
    5 mg OD/
/
4.	Linagliptin :/
-	Formulation: 5 mg /
    o	Minimum dose/
    5 mg OD /
    o	Maximum dose/
    5 mg OD/
/
SGLT2-inhibitors/
1.	Dapagliflozin :/
-	Formulation: 5/10 mg /
    o	Minimum dose/
    5 mg OD /
    o	Maximum dose/
    10 mg OD/
/
2.	Canagliflozin :/
-	Formulation: 100/300 mg /
    o	Minimum dose/
    100 mg OD/
    o	Maximum dose/
    300 mg OD/
/
3.	Empagliflozin :/
-	Formulation: 10/25 mg /
    o	Minimum dose/
    10 mg OD /
    o	Maximum dose/
    25 mg OD/
/
4.	Luseogliflozin :/
-	Formulation: 2.5/5 mg /
    o	Minimum dose/
    2.5 mg OD /
    o	Maximum dose/
    5 mg OD/
/
5.	Ertugliflozin :/
-	Formulation: 5/15 mg/
    o	Minimum dose/
    5 mg OD/
    o	Maximum dose /
    15 mg OD/
/
GLP1-RA/
1.	Exenatide Immediate Release :/
-	Formulation: 5 μg/20 μL; 10 μg/40 μL /
    o	Minimum dose/
    5 μg BD /
    o	Maximum dose/
    10 μg BD/
/
2.	Exenatide Extended Release :/
-	Formulation: 2 mg /
    o	Minimum dose/
    2 mg weekly/
    o	Maximum dose /
    2 mg weekly/
/
3.	Dulaglutide :/
-	Formulation: 0.75 mg/1.5 mg /
    o	Minimum /
    0.75 mg weekly/
    o	Maximum dose/
    1.5 mg weekly/
/
4.	Liraglutide :/
-	Formulation: 6 mg/mL /
    o	Minimum dose/
    0.6 mg OD /
    o	Maximum dose/
    1.8 mg OD/
/
5.	Lixisenatide :/
-	Formulation: 50 μg/mL; 100 μg/mL /
    o	Minimum dose/
    10 μg OD/
    o	Maximum dose/
    20 μg OD/
/
6.	Semaglutide :/
-	Formulation: 0.25/0.5 mg /
    o	Minimum dose/
    0.25 weekly/
    o	Maximum dose /
    1.0 mg weekly/